{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:07:13Z","timestamp":1786975633356,"version":"build-2736575974"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Selective serotonin reuptake inhibitors (SSRIs) are considered a first-line pharmacological treatment for adolescent depression with moderate or higher levels of symptom severity. Thus, it is important to understand neurobiological changes related to SSRIs during the course of treatment for adolescents with depression.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine neurobiological changes associated with SSRI treatment in adolescents with major depressive disorder (MDD) by measuring longitudinal changes in volume and resting-state functional connectivity (rsFC) in the dorsolateral prefrontal cortex (DLPFC), a core region of cognitive control.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study was conducted with an open-label design. Adolescents with MDD and healthy controls were recruited at the Seoul National University Hospital (Seoul, South Korea). Adolescents with MDD were treated with escitalopram for 8 weeks. Data analysis was conducted between April 2021 and February 2022.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Depressive symptoms were assessed using the Children\u2019s Depression Rating Scale\u2013Revised. The outcome measure was defined as the change in Children\u2019s Depression Rating Scale\u2013Revised scores from week 0 (before treatment) to week 8 (after treatment) or upon termination. Participants completed structural and resting-state functional magnetic resonance imaging (rsfMRI) assessments before (week 0) and after (week 8) SSRI treatment. Repeated measures analysis of variance and liner mixed model analyses were used to examine the longitudinal associations of SSRI treatment with DLPFC volume and rsFC between responders who showed at least a 40% decrease in depressive symptoms and nonresponders who did not.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Ninety-five adolescents with MDD and 57 healthy controls were initially recruited. The final analyses of volume included 36 responders (mean [SD] age, 15.0 [1.6] years; 25 girls [69.4%]) and 26 nonresponders (mean [SD] age, 15.3 [1.5] years; 19 girls [73.1%]). Analyses of rsFC included 33 responders (mean [SD] age, 15.2 [1.5] years; 21 girls [63.6%]) and 26 nonresponders (mean [SD] age, 15.3 [1.5] years; 19 girls [73.1%]). The longitudinal associations of SSRI treatment were more evident in responders than in nonresponders. Responders showed significantly increased right DLPFC volume, decreased bilateral DLPFC rsFC with the superior frontal gyri, and decreased left DLPFC rsFC with the ventromedial PFC after treatment compared with before treatment. Furthermore, increased right DLPFC volume was correlated with decreased rsFC between the right DLPFC and superior frontal gyri after SSRI treatment.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n The preliminary results of this cohort study suggest that the DLPFC volumetric and rsFC changes may serve as potential neurobiological treatment markers that are associated with symptom improvement in adolescents with MDD.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.27331","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T11:31:26Z","timestamp":1691148686000},"page":"e2327331","source":"Crossref","is-referenced-by-count":31,"title":["Measures of Connectivity and Dorsolateral Prefrontal Cortex Volumes and Depressive Symptoms Following Treatment With Selective Serotonin Reuptake Inhibitors in Adolescents"],"prefix":"10.1001","volume":"6","author":[{"given":"Kyung Hwa","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoon","family":"Shin","sequence":"additional","affiliation":[{"name":"Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung","family":"Lee","sequence":"additional","affiliation":[{"name":"Integrative Care Hub, Seoul National University Children\u2019s Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyun","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The Catholic University of Korea, Seoul St Mary\u2019s Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Won","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Brent","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"zoi230791r1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jad.2021.03.022","article-title":"Prescribing trends of antidepressants and psychotropic coprescription for youths in UK primary care, 2000-2018.","volume":"287","author":"Cao","year":"2021","journal-title":"J Affect Disord"},{"issue":"3","key":"zoi230791r2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.euroneuro.2016.02.001","article-title":"Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012.","volume":"26","author":"Bachmann","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"zoi230791r3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/CHI.0b013e31819176f9","article-title":"Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes.","volume":"48","author":"Kennard","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"zoi230791r4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.biopsych.2014.08.009","article-title":"Depression, neuroimaging and connectomics: a selective overview.","volume":"77","author":"Gong","year":"2015","journal-title":"Biol Psychiatry"},{"issue":"9820","key":"zoi230791r5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0140-6736(11)60602-8","article-title":"Major depressive disorder: new clinical, neurobiological, and treatment perspectives.","volume":"379","author":"Kupfer","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"zoi230791r6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/cap.2015.0232","article-title":"Neural correlates of antidepressant treatment response in adolescents with major depressive disorder.","volume":"26","author":"Cullen","year":"2016","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"zoi230791r7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","article-title":"Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity.","volume":"72","author":"Kaiser","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"zoi230791r8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbr.2009.03.004","article-title":"The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex.","volume":"201","author":"Koenigs","year":"2009","journal-title":"Behav Brain Res"},{"issue":"1","key":"zoi230791r9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41386-021-01101-7","article-title":"Prefrontal cortex and depression.","volume":"47","author":"Pizzagalli","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"zoi230791r10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jad.2012.07.029","article-title":"Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex.","volume":"146","author":"Smith","year":"2013","journal-title":"J Affect Disord"},{"issue":"4","key":"zoi230791r11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.biopsych.2015.02.037","article-title":"Frontoparietal activation during response inhibition predicts remission to antidepressants in patients with major depression.","volume":"79","author":"Gyurak","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"11","key":"zoi230791r12","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1177\/0269881112450779","article-title":"Functional neuroanatomy of emotion processing in major depressive disorder is altered after successful antidepressant therapy.","volume":"26","author":"Rosenblau","year":"2012","journal-title":"J Psychopharmacol"},{"issue":"3","key":"zoi230791r13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1017\/S0033291716002440","article-title":"Resting-state brain alteration after a single dose of SSRI administration predicts 8-week remission of patients with major depressive disorder.","volume":"47","author":"Cheng","year":"2017","journal-title":"Psychol Med"},{"issue":"8","key":"zoi230791r14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/pcn.v76.8","article-title":"Left DLPFC activity is associated with plasma kynurenine levels and can predict treatment response to escitalopram in major depressive disorder.","volume":"76","author":"Kamishikiryo","year":"2022","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"zoi230791r15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tics.2017.01.003","article-title":"Neural perspectives on cognitive control development during childhood and adolescence.","volume":"21","author":"Crone","year":"2017","journal-title":"Trends Cogn Sci"},{"issue":"1","key":"zoi230791r16","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41398-021-01754-4","article-title":"Effects of escitalopram therapy on resting-state functional connectivity of subsystems of the default mode network in unmedicated patients with major depressive disorder.","volume":"11","author":"Cui","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"2","key":"zoi230791r17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/hbm.v36.2","article-title":"The effects of antidepressant treatment on resting-state functional brain networks in patients with major depressive disorder.","volume":"36","author":"Wang","year":"2015","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"zoi230791r18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biopsych.2012.12.024","article-title":"Relation between structural and functional connectivity in major depressive disorder.","volume":"74","author":"de Kwaasteniet","year":"2013","journal-title":"Biol Psychiatry"},{"key":"zoi230791r21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jad.2020.01.045","article-title":"Early changes of serum BDNF and SSRI response in adolescents with major depressive disorder.","volume":"265","author":"Lee","year":"2020","journal-title":"J Affect Disord"},{"issue":"5","key":"zoi230791r22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaac.2011.01.018","article-title":"Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial.","volume":"50","author":"Woldu","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"zoi230791r24","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv037","article-title":"A prospective, longitudinal study of the effect of remission on cortical thickness and hippocampal volume in patients with treatment-resistant depression.","volume":"18","author":"Phillips","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"zoi230791r25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1001\/jamapsychiatry.2018.0123","article-title":"Association of brain cortical changes with relapse in patients with major depressive disorder.","volume":"75","author":"Zaremba","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"zoi230791r26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrn.2016.69","article-title":"Integrating neuroimmune systems in the neurobiology of depression.","volume":"17","author":"Wohleb","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"24","key":"zoi230791r27","doi-asserted-by":"publisher","first-page":"11020","DOI":"10.1073\/pnas.1000446107","article-title":"Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus.","volume":"107","author":"Sheline","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"zoi230791r28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuroimage.2018.06.024","article-title":"An approach to directly link ICA and seed-based functional connectivity: application to schizophrenia.","volume":"179","author":"Wu","year":"2018","journal-title":"Neuroimage"},{"key":"zoi230791r19","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"zoi230791r20","volume-title":"Schedule for Affective Disorders and Schizophrenia for School-Age Children: Present and Lifetime Version (K-SADS-PL 2013, DSM-5)","author":"Kaufman","year":"2013"},{"key":"zoi230791r23","volume-title":"Children\u2019s Depression Rating Scale, Revised (CDRS-R) Manual","author":"Poznanski","year":"1996"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2808079\/lee_2023_oi_230791_1690559480.87951.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T11:31:35Z","timestamp":1691148695000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2808079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.27331","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]}}}